Enterprise Value to EBITDA Ratio: Equillium Bio (EQ)
The visual representation of EV/EBITDA multiples for Equillium, Inc. (EQ) is 0.00. The business's success relies on the implementation of itolizumab for autoimmune pathologies, the partnership with Ono Pharmaceutical, and clinical trial results. High brand authority among immunologists guarantees shareholder support, while collaboration with biotech laboratories enables the creation of receptor-blocking methods to combat acute inflammation.
EQ (equilliumbio.com): analytical breakdowns and indicator data
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
EQ - Company Net Income|Expected Profit Equillium, Inc.|EQ - Price to Earnings Ratio|Forward P/E Multiple Equillium|EQ - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio EQ|EQ - Operating profit EBITDA|Earnings per share for the last twelve months Equillium|EQ - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months equilliumbio.com|EQ - Earnings per share increase in current year|Earnings growth forecast for next year Equillium, Inc.
Basic company analysis:Equillium Bio (EQ)
For Equillium, Inc., which is developing a pipeline of immunomodulating antibodies, this indicator serves as a measure of capital resilience during costly Phase II clinical trials. By analyzing the company's Enterprise Value to EBITDA ratio, an investor assesses the total business value, including debt, relative to operating profit, which helps identify market overvaluations or hidden asset discounts during periods of volatility.
Competitors of Equillium, Inc.
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Argenx ARGX|BNTX - Enterprise Value to EBITDA Ratio|ABVX: Enterprise Value to EBITDA Ratio|ADMA - EV/EBITDA Multiple|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation IMVT|KNSA (Kiniksa Pharmaceuticals Ltd) - EV/EBITDA Multiple|Company Value to EBITDA Grifols Biemat GRFS|EV/EBITDA Multiple ADPT|CLDX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aurinia Pharmaceuticals Inc. AUPH|Enterprise Value to EBITDA Multiple BioCryst Pharmaceuticals, Inc.|VERA: Enterprise Value to EBITDA Ratio|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|ABCL - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PGEN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pharming (PHAR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NKTR (Nektar Corp)|EV/EBITDA Multiple UPB (Upstream Bio Inc)|Total Company Value to Operating Income Before Depreciation Ratio zenasbio.com (ZBIO)|IMNM: Enterprise Value to EBITDA Ratio|GOSS - EV/EBITDA Multiple|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Septerna Pharma|Enterprise Value to EBITDA Ratio PVLA|SVRA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|ENGN: Enterprise Value to Operating Income Before Depreciation|RAPT Therapeutics - EV/EBITDA Multiple|Aerovate Therapeutics Inc (JBIO) - Enterprise Value to EBITDA Ratio|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Company Value to EBITDA Cabaletta Bio Inc CABA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|theratech.com (THTX) - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Company Value to Operating Income Before Depreciation Ratio|Agenus Inc - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CLYM (Climb Bio, Inc)|ZURA: EV/EBITDA Multiple|atyrpharma.com (ATYR) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|IMA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Labs, Inc. (STTK)|Enterprise Value to EBITDA Ratio connectbiopharm.com CNTB|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|ACET: EV/EBITDA Multiple|CELU - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOVX (geovax.com) - Enterprise Value to Operating Income Before Depreciation|EDSA: EV/EBITDA Multiple|Company Value to EBITDA iBio Inc (IBIO)|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|Company Value to EBITDA XTL Bio XTLB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|hcwbiologics.com (HCWB) - Enterprise Value to EBITDA Multiple|Aptevo Therapeutics Inc. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple aimimmuno.com AIM|Aditxt Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio GRI Bio Corporation GRI|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HIND (reshapelifesciences.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INDP|EV/EBITDA Multiple SCNI|Total Company Value to Operating Income Before Depreciation Ratio calcimedica.com|Affimed N.V. - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Allakos Inc ALLK|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|IGM Biosciences, Inc. (IGMS) - Enterprise Value to EBITDA Ratio|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
